Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Influenza

Free Subscription 16.08.2021 3 Am J Med 1 Antiviral Res 2 Arch Virol 1 BMC Pediatr 7 BMJ 3 Epidemiol Infect 7 Eur J Epidemiol 6 J Epidemiol Community Health 1 J Gen Virol 3 J Immunol 1 J Infect 6 J Infect Dis 3 J Virol 4 JAMA 8 Lancet 6 MMWR Morb Mortal Wkly Rep 7 N Engl J Med 4 Pediatrics 5 PLoS Comput Biol 25 PLoS One 2 Proc Natl Acad Sci U S A 14 Vaccine 1 Virology 5 Virus Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Med

1. PATEL P, Dhindsa D, Eapen DJ, Khera A, et al
   OPTIMIZING THE POTENTIAL FOR TELEHEALTH IN CARDIOVASCULAR CARE (IN THE ERA OF COVID-19): TIME WILL TELL.
   Am J Med. 2021 Apr 9. pii: S0002-9343(21)00218.
   PubMed         Abstract available
   
   
2. BOULANGER M, Molina E, Wang K, Kickler T, et al
   Peripheral Plasma Cells Associated with Mortality Benefit in Severe COVID-19: A Marker of Disease Resolution.
   Am J Med. 2021;134:1029-1033.
   PubMed         Abstract available
   
   
3. FRISHMAN WH, Alpert JS
   Virtual Interviews During Internal Medicine Recruitments: An Unexpected Favorable Outcome of the COVID-19 Pandemic?
   Am J Med. 2021;134:935-936.
   PubMed        
   
   

   
   Antiviral Res

4. ISON MG, Hayden FG, Hay AJ, Gubareva LV, et al
   Influenza polymerase inhibitor resistance: Assessment of the current state of the art - A report of the isirv Antiviral group.
   Antiviral Res. 2021;194:105158.
   PubMed         Abstract available
   
   

   
   Arch Virol

5. BOONARKART C, Suptawiwat O, Ruangrung K, Maneechotesuwan K, et al
   Microparticles from human the lower airway show inhibitory activity against respiratory syncytial virus.
   Arch Virol. 2021;166:2579-2584.
   PubMed         Abstract available
   
   
6. MA Y, Jiang H, Wan Z, Li S, et al
   Evolutionary dynamics of group A and B respiratory syncytial virus in China, 2009-2018.
   Arch Virol. 2021;166:2407-2418.
   PubMed         Abstract available
   
   

   
   BMC Pediatr

7. REIFF DD, Meyer CG, Marlin B, Mannion ML, et al
   New onset ANCA-associated vasculitis in an adolescent during an acute COVID-19 infection: a case report.
   BMC Pediatr. 2021;21:333.
   PubMed         Abstract available
   
   

   
   BMJ

8. DAVIDSON SL, Menkes DB
   Long covid: reshaping conversations about medically unexplained symptoms.
   BMJ. 2021;374:n1859.
   PubMed        
   
   
9. MALCOLM RS
   Chronic fatigue syndrome and long covid: individualisation, not compartmentalisation.
   BMJ. 2021;374:n1863.
   PubMed        
   
   
10. BAMJI AN
    Infection with SARS-CoV-2 is not the same as covid-19.
    BMJ. 2021;374:n1896.
    PubMed        
    
    
11. ERFANI P, Binagwaho A, Jalloh MJ, Yunus M, et al
    Intellectual property waiver for covid-19 vaccines will advance global health equity.
    BMJ. 2021;374:n1837.
    PubMed        
    
    
12. FLOURIS AD, Babar Z, Ioannou LG, Onarheim KH, et al
    Improving the evidence on health inequities in migrant construction workers preparing for big sporting events.
    BMJ. 2021;374:n1615.
    PubMed        
    
    
13. ONARHEIM KH, Phua KH, Babar ZR, Flouris AD, et al
    Health and social needs of migrant construction workers for big sporting events.
    BMJ. 2021;374:n1591.
    PubMed        
    
    
14. STOCKL H, Quigg Z
    Violence against women and girls.
    BMJ. 2021;374:n1926.
    PubMed        
    
    

    
    Epidemiol Infect

15. YI B, Poetsch AR, Stadtmuller M, Rost F, et al
    Phylogenetic analysis of SARS-CoV-2 lineage development across the first and second waves in Eastern Germany in 2020: insights into the cause of the second wave.
    Epidemiol Infect. 2021;149:e177.
    PubMed         Abstract available
    
    
16. OTTAVIANO E, Parodi C, Borghi E, Massa V, et al
    Saliva detection of SARS-CoV-2 for mitigating company outbreaks: a surveillance experience, Milan, Italy, March 2021.
    Epidemiol Infect. 2021;149:e171.
    PubMed         Abstract available
    
    
17. KELLY G, Petti S, Noah N
    Covid-19, non-Covid-19 and excess mortality rates not comparable across countries.
    Epidemiol Infect. 2021;149:e176.
    PubMed         Abstract available
    
    

    
    Eur J Epidemiol

18. SCHMITZ T, Meisinger C, Kirchberger I, Thilo C, et al
    Impact of COVID-19 pandemic lockdown on myocardial infarction care.
    Eur J Epidemiol. 2021;36:619-627.
    PubMed         Abstract available
    
    
19. FERENCI T
    Different approaches to quantify years of life lost from COVID-19.
    Eur J Epidemiol. 2021;36:589-597.
    PubMed         Abstract available
    
    
20. POZO-MARTIN F, Weishaar H, Cristea F, Hanefeld J, et al
    The impact of non-pharmaceutical interventions on COVID-19 epidemic growth in the 37 OECD member states.
    Eur J Epidemiol. 2021;36:629-640.
    PubMed         Abstract available
    
    
21. NAFILYAN V, Islam N, Mathur R, Ayoubkhani D, et al
    Ethnic differences in COVID-19 mortality during the first two waves of the Coronavirus Pandemic: a nationwide cohort study of 29 million adults in England.
    Eur J Epidemiol. 2021;36:605-617.
    PubMed         Abstract available
    
    
22. LUNDBERG JO, Zeberg H
    Longitudinal variability in mortality predicts COVID-19 deaths.
    Eur J Epidemiol. 2021;36:599-603.
    PubMed         Abstract available
    
    
23. LICHER S, Terzikhan N, Splinter MJ, Velek P, et al
    Design, implementation and initial findings of COVID-19 research in the Rotterdam Study: leveraging existing infrastructure for population-based investigations on an emerging disease.
    Eur J Epidemiol. 2021;36:649-654.
    PubMed         Abstract available
    
    
24. IOANNIDIS JPA
    Over- and under-estimation of COVID-19 deaths.
    Eur J Epidemiol. 2021;36:581-588.
    PubMed         Abstract available
    
    

    
    J Epidemiol Community Health

25. WRIGHT L, Steptoe A, Fancourt D
    Does thinking make it so? Differential associations between adversity worries and experiences and mental health during the COVID-19 pandemic.
    J Epidemiol Community Health. 2021;75:817-823.
    PubMed         Abstract available
    
    
26. MO Q, Chen X, Yu B, Ma Z, et al
    Levels of economic growth and cross-province spread of the COVID-19 in China.
    J Epidemiol Community Health. 2021;75:824-828.
    PubMed         Abstract available
    
    
27. ANDERSEN J, Strandberg-Larsen K, Gerds T, Gislason G, et al
    Risk of major cardiovascular events according to educational level before and after the initial COVID-19 public lockdown: a nationwide study.
    J Epidemiol Community Health. 2021;75:829-835.
    PubMed         Abstract available
    
    
28. FAN FC, Zhang SY, Cheng Y
    Incidence of psychological illness after coronavirus outbreak: a meta-analysis study.
    J Epidemiol Community Health. 2021;75:836-842.
    PubMed         Abstract available
    
    
29. CAMPBELL M, Marek L, Wiki J, Hobbs M, et al
    National movement patterns during the COVID-19 pandemic in New Zealand: the unexplored role of neighbourhood deprivation.
    J Epidemiol Community Health. 2021;75:903-905.
    PubMed         Abstract available
    
    
30. DEMAKAKOS P
    Importance of population-based longitudinal studies to understanding the impact of COVID-19.
    J Epidemiol Community Health. 2021;75:815-816.
    PubMed        
    
    

    
    J Gen Virol

31. POHL MO, Busnadiego I, Marrafino F, Wiedmer L, et al
    Combined computational and cellular screening identifies synergistic inhibition of SARS-CoV-2 by lenvatinib and remdesivir.
    J Gen Virol. 2021;102.
    PubMed         Abstract available
    
    

    
    J Immunol

32. BAYARRI-OLMOS R, Idorn M, Rosbjerg A, Perez-Alos L, et al
    SARS-CoV-2 Neutralizing Antibody Responses towards Full-Length Spike Protein and the Receptor-Binding Domain.
    J Immunol. 2021;207:878-887.
    PubMed         Abstract available
    
    
33. SHAHBAZ S, Xu L, Sligl W, Osman M, et al
    The Quality of SARS-CoV-2-Specific T Cell Functions Differs in Patients with Mild/Moderate versus Severe Disease, and T Cells Expressing Coinhibitory Receptors Are Highly Activated.
    J Immunol. 2021;207:1099-1111.
    PubMed         Abstract available
    
    
34. OCHSNER SP, Li W, Rajendrakumar AM, Palaniyandi S, et al
    FcRn-Targeted Mucosal Vaccination against Influenza Virus Infection.
    J Immunol. 2021 Aug 11. pii: jimmunol.2100297. doi: 10.4049/jimmunol.2100297.
    PubMed         Abstract available
    
    

    
    J Infect

35. ZHANG J, Huang L, Chen Y, Wang X, et al
    Avian influenza H10 subtype viruses continuously pose threat to public health in China.
    J Infect. 2021 Aug 6. pii: S0163-4453(21)00386.
    PubMed        
    
    

    
    J Infect Dis

36. BIANCHI FP, Germinario CA, Migliore G, Vimercati L, et al
    BNT162b2 mRNA Covid-19 vaccine effectiveness in the prevention of SARS-CoV-2 infection: a preliminary report.
    J Infect Dis. 2021 May 19. pii: 6278131. doi: 10.1093.
    PubMed         Abstract available
    
    
37. HALL JA, Harris RJ, Emmett HE, Lowe B, et al
    On the Sensitivity and Specificity of Postmortem Upper Respiratory Tract Testing for SARS-CoV-2.
    J Infect Dis. 2021;224:389-394.
    PubMed         Abstract available
    
    
38. CHA S, Henry A, Montgomery MP, Laws RL, et al
    Morbidity and Mortality among Adults Experiencing Homelessness Hospitalized with COVID-19.
    J Infect Dis. 2021 May 16. pii: 6276529. doi: 10.1093.
    PubMed         Abstract available
    
    
39. MEISTER TL, Fortmann J, Todt D, Heinen N, et al
    Comparable Environmental Stability and Disinfection Profiles of the Currently Circulating SARS-CoV-2 Variants of Concern B.1.1.7 and B.1.351.
    J Infect Dis. 2021;224:420-424.
    PubMed         Abstract available
    
    
40. ALKHARAAN H, Bayati S, Hellstrom C, Aleman S, et al
    Persisting Salivary IgG Against SARS-CoV-2 at 9 Months After Mild COVID-19: A Complementary Approach to Population Surveys.
    J Infect Dis. 2021;224:407-414.
    PubMed         Abstract available
    
    
41. BOUMAZA A, Gay L, Mezouar S, Bestion E, et al
    Monocytes and Macrophages, Targets of Severe Acute Respiratory Syndrome Coronavirus 2: The Clue for Coronavirus Disease 2019 Immunoparalysis.
    J Infect Dis. 2021;224:395-406.
    PubMed         Abstract available
    
    

    
    J Virol

42. TAM EH, Liu YC, Woung CH, Liu HM, et al
    Role of the chaperone protein 14-3-3epsilon in the regulation of influenza A virus-activated beta interferon.
    J Virol. 2021 Aug 11:JVI0023121. doi: 10.1128/JVI.00231.
    PubMed         Abstract available
    
    
43. KAWAI A, Yamamoto Y, Nogimori T, Takeshita K, et al
    The potential of neuraminidase as an antigen for nasal vaccines to increase cross-protection against influenza viruses.
    J Virol. 2021 Aug 11:JVI0118021. doi: 10.1128/JVI.01180.
    PubMed         Abstract available
    
    
44. KAPLAN BS, Anderson TK, Chang J, Santos J, et al
    Evolution and antigenic advancement of N2 neuraminidase of swine influenza A viruses circulating in the United States following two separate introductions from human seasonal viruses.
    J Virol. 2021 Aug 11:JVI0063221. doi: 10.1128/JVI.00632.
    PubMed         Abstract available
    
    

    
    JAMA

45. HOLTGRAVE DR, Vermund SH, Wen LS
    Potential Benefits of Expanded COVID-19 Surveillance in the US.
    JAMA. 2021 Jul 15. pii: 2782163. doi: 10.1001/jama.2021.11211.
    PubMed        
    
    
46. ABBASI J
    Study Suggests Lasting Immunity After COVID-19, With a Big Boost From Vaccination.
    JAMA. 2021 Jul 14. pii: 2782139. doi: 10.1001/jama.2021.11717.
    PubMed        
    
    
47. KOFMAN A, Kantor R, Adashi EY
    Potential COVID-19 Endgame Scenarios: Eradication, Elimination, Cohabitation, or Conflagration?
    JAMA. 2021 Jul 8. pii: 2781945. doi: 10.1001/jama.2021.11042.
    PubMed        
    
    
48. MATTHAY MA, Luetkemeyer AF
    IL-6 Receptor Antagonist Therapy for Patients Hospitalized for COVID-19: Who, When, and How?
    JAMA. 2021 Jul 6. pii: 2781881. doi: 10.1001/jama.2021.11121.
    PubMed        
    
    

    
    Lancet

49. PEYRE M, Vourc'h G, Lefrancois T, Martin-Prevel Y, et al
    PREZODE: preventing zoonotic disease emergence.
    Lancet. 2021;397:792-793.
    PubMed        
    
    
50. BLACK C
    Treatment for drug dependence in England needs investment and reform.
    Lancet. 2021;398:474-476.
    PubMed        
    
    
51. ABBAS K, Mogasale V
    Disruptions to childhood immunisation due to the COVID-19 pandemic.
    Lancet. 2021 Jul 14. pii: S0140-6736(21)01418.
    PubMed        
    
    
52. THE LANCET
    COVID-19 in Africa: a lesson in solidarity.
    Lancet. 2021;398:185.
    PubMed        
    
    
53. FISSEHA S, Sen G, Ghebreyesus TA, Byanyima W, et al
    COVID-19: the turning point for gender equality.
    Lancet. 2021 Jul 16. pii: S0140-6736(21)01651.
    PubMed        
    
    
54. DEVI S
    Mediterranean migrants lacking health care.
    Lancet. 2021;398:479-480.
    PubMed        
    
    
55. LEE N
    Lucy Chappell: setting the agenda for UK research policy.
    Lancet. 2021;398:481.
    PubMed        
    
    
56. BICCARD BM, Thomson D, Miller M, Taylor EH, et al
    Critically ill COVID-19 patients in Africa: it is time for quality registry data - Authors' reply.
    Lancet. 2021;398:486-487.
    PubMed        
    
    

    
    MMWR Morb Mortal Wkly Rep

57. BROWN CM, Vostok J, Johnson H, Burns M, et al
    Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gatherings - Barnstable County, Massachusetts, July 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1059-1062.
    PubMed         Abstract available
    
    
58. YOON P, Hall J, Fuld J, Mattocks SL, et al
    Alternative Methods for Grouping Race and Ethnicity to Monitor COVID-19 Outcomes and Vaccination Coverage.
    MMWR Morb Mortal Wkly Rep. 2021;70:1075-1080.
    PubMed         Abstract available
    
    
59. MOLINE HL, Whitaker M, Deng L, Rhodes JC, et al
    Effectiveness of COVID-19 Vaccines in Preventing Hospitalization Among Adults Aged >/=65 Years - COVID-NET, 13 States, February-April 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1088-1093.
    PubMed         Abstract available
    
    
60. CAVANAUGH AM, Spicer KB, Thoroughman D, Glick C, et al
    Reduced Risk of Reinfection with SARS-CoV-2 After COVID-19 Vaccination - Kentucky, May-June 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1081-1083.
    PubMed         Abstract available
    
    
61. HERLIHY R, Bamberg W, Burakoff A, Alden N, et al
    Rapid Increase in Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - Mesa County, Colorado, April-June 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1084-1087.
    PubMed         Abstract available
    
    
62. ROSENBLUM HG, Hadler SC, Moulia D, Shimabukuro TT, et al
    Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July
    MMWR Morb Mortal Wkly Rep. 2021;70:1094-1099.
    PubMed         Abstract available
    
    

    
    N Engl J Med

63. LIU Y, Liu J, Xia H, Zhang X, et al
    BNT162b2-Elicited Neutralization against New SARS-CoV-2 Spike Variants.
    N Engl J Med. 2021 May 12. doi: 10.1056/NEJMc2106083.
    PubMed        
    
    
64. WHITE EM, Yang X, Blackman C, Feifer RA, et al
    Incident SARS-CoV-2 Infection among mRNA-Vaccinated and Unvaccinated Nursing Home Residents.
    N Engl J Med. 2021 May 19. doi: 10.1056/NEJMc2104849.
    PubMed        
    
    
65. O'CONNELL J, O'Keeffe DT
    Contact Tracing for Covid-19 - A Digital Inoculation against Future Pandemics.
    N Engl J Med. 2021 May 19. doi: 10.1056/NEJMp2102256.
    PubMed        
    
    
66. BECKER SJ, Taylor J, Sharfstein JM
    Identifying and Tracking SARS-CoV-2 Variants - A Challenge and an Opportunity.
    N Engl J Med. 2021 Jun 9. doi: 10.1056/NEJMp2103859.
    PubMed        
    
    
67. SAMARAKOON U, Alvarez-Arango S, Blumenthal KG
    Delayed Large Local Reactions to mRNA Covid-19 Vaccines in Blacks, Indigenous Persons, and People of Color.
    N Engl J Med. 2021 Jun 9. doi: 10.1056/NEJMc2108620.
    PubMed        
    
    
68. GUIMARAES PO, Quirk D, Furtado RH, Maia LN, et al
    Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia.
    N Engl J Med. 2021;385:406-415.
    PubMed         Abstract available
    
    
69. COREY L, Beyrer C, Cohen MS, Michael NL, et al
    SARS-CoV-2 Variants in Patients with Immunosuppression.
    N Engl J Med. 2021;385:562-566.
    PubMed        
    
    

    
    Pediatrics

70. NAIFEH MM, Stevenson MD, Abramson EL, Aston CE, et al
    Early Impact of the COVID-19 Pandemic on Pediatric Resident Workforce.
    Pediatrics. 2021;148.
    PubMed        
    
    
71. FAROOQI KM, Chan A, Weller RJ, Mi J, et al
    Longitudinal Outcomes for Multisystem Inflammatory Syndrome in Children.
    Pediatrics. 2021;148.
    PubMed         Abstract available
    
    
72. PERSSON J, Shorofsky M, Leahy R, Friesen R, et al
    ST-Elevation Myocardial Infarction due to Acute Thrombosis in an Adolescent With COVID-19.
    Pediatrics. 2021;148.
    PubMed         Abstract available
    
    
73. HADDADIN Z, Schuster JE, Spieker AJ, Rahman H, et al
    Acute Respiratory Illnesses in Children in the SARS-CoV-2 Pandemic: Prospective Multicenter Study.
    Pediatrics. 2021;148.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

74. CAZELLES B, Champagne C, Nguyen-Van-Yen B, Comiskey C, et al
    A mechanistic and data-driven reconstruction of the time-varying reproduction number: Application to the COVID-19 epidemic.
    PLoS Comput Biol. 2021;17:e1009211.
    PubMed         Abstract available
    
    
75. KERR CC, Stuart RM, Mistry D, Abeysuriya RG, et al
    Covasim: An agent-based model of COVID-19 dynamics and interventions.
    PLoS Comput Biol. 2021;17:e1009149.
    PubMed         Abstract available
    
    
76. PARISI A, Brand SPC, Hilton J, Aziza R, et al
    Spatially resolved simulations of the spread of COVID-19 in three European countries.
    PLoS Comput Biol. 2021;17:e1009090.
    PubMed         Abstract available
    
    
77. PINKY L, Burke CW, Russell CJ, Smith AM, et al
    Quantifying dose-, strain-, and tissue-specific kinetics of parainfluenza virus infection.
    PLoS Comput Biol. 2021;17:e1009299.
    PubMed         Abstract available
    
    
78. HINCH R, Probert WJM, Nurtay A, Kendall M, et al
    OpenABM-Covid19-An agent-based model for non-pharmaceutical interventions against COVID-19 including contact tracing.
    PLoS Comput Biol. 2021;17:e1009146.
    PubMed         Abstract available
    
    

    
    PLoS One

79. WANG Y, Yang J, Ma H, Dong X, et al
    Application of telemedicine in the COVID-19 epidemic: An analysis of Gansu Province in China.
    PLoS One. 2021;16:e0249872.
    PubMed         Abstract available
    
    
80. ANAND V, Verma L, Aggarwal A, Nanjundappa P, et al
    COVID-19 and psychological distress: Lessons for India.
    PLoS One. 2021;16:e0255683.
    PubMed         Abstract available
    
    
81. HERRMANN Y, Starck T, Brindl N, Kitchen PJ, et al
    Description and analysis of representative COVID-19 cases-A retrospective cohort study.
    PLoS One. 2021;16:e0255513.
    PubMed         Abstract available
    
    
82. CALLI E, Murphy K, Kurstjens S, Samson T, et al
    Deep learning with robustness to missing data: A novel approach to the detection of COVID-19.
    PLoS One. 2021;16:e0255301.
    PubMed         Abstract available
    
    
83. KUHN R, Henwood B, Lawton A, Kleva M, et al
    COVID-19 vaccine access and attitudes among people experiencing homelessness from pilot mobile phone survey in Los Angeles, CA.
    PLoS One. 2021;16:e0255246.
    PubMed         Abstract available
    
    
84. SANDOVAL M, Nguyen DT, Vahidy FS, Graviss EA, et al
    Risk factors for severity of COVID-19 in hospital patients age 18-29 years.
    PLoS One. 2021;16:e0255544.
    PubMed         Abstract available
    
    
85. MILLIGAN WR, Fuller ZL, Agarwal I, Eisen MB, et al
    Impact of essential workers in the context of social distancing for epidemic control.
    PLoS One. 2021;16:e0255680.
    PubMed         Abstract available
    
    
86. INOUE H, Murase Y, Todo Y
    Do economic effects of the anti-COVID-19 lockdowns in different regions interact through supply chains?
    PLoS One. 2021;16:e0255031.
    PubMed         Abstract available
    
    
87. BERRY DA, Ip A, Lewis BE, Berry SM, et al
    Development and validation of a prognostic 40-day mortality risk model among hospitalized patients with COVID-19.
    PLoS One. 2021;16:e0255228.
    PubMed         Abstract available
    
    
88. LEBEDEV M, McEligot HA, Mutua VN, Walsh P, et al
    Analysis of lung transcriptome in calves infected with Bovine Respiratory Syncytial Virus and treated with antiviral and/or cyclooxygenase inhibitor.
    PLoS One. 2021;16:e0246695.
    PubMed         Abstract available
    
    
89. SAYED MH, Hegazi MA, El-Baz MS, Alahmadi TS, et al
    COVID-19 related posttraumatic stress disorder in children and adolescents in Saudi Arabia.
    PLoS One. 2021;16:e0255440.
    PubMed         Abstract available
    
    
90. WU Z
    Social distancing is a social dilemma game played by every individual against his/her population.
    PLoS One. 2021;16:e0255543.
    PubMed         Abstract available
    
    
91. BELL ML, Catalfamo CJ, Farland LV, Ernst KC, et al
    Post-acute sequelae of COVID-19 in a non-hospitalized cohort: Results from the Arizona CoVHORT.
    PLoS One. 2021;16:e0254347.
    PubMed         Abstract available
    
    
92. KAMALOV F, Sulieman H, Santandreu Calonge D
    Machine learning based approach to exam cheating detection.
    PLoS One. 2021;16:e0254340.
    PubMed         Abstract available
    
    
93. RICKE-HOCH M, Stelling E, Lasswitz L, Gunesch AP, et al
    Impaired immune response mediated by prostaglandin E2 promotes severe COVID-19 disease.
    PLoS One. 2021;16:e0255335.
    PubMed         Abstract available
    
    
94. RADULESCU A, Ballard S, Gonzalez K, Linton J, et al
    Dynamic coupling between the COVID-19 epidemic timeline and the behavioral response to PAUSE in New York State counties.
    PLoS One. 2021;16:e0255236.
    PubMed         Abstract available
    
    
95. KASSAS B, Morgan SN, Lai JH, Kropp JD, et al
    Perception versus preference: The role of self-assessed risk measures on individual mitigation behaviors during the COVID-19 pandemic.
    PLoS One. 2021;16:e0254756.
    PubMed         Abstract available
    
    
96. DAWSON N, Williams MA, Rizoiu MA
    Skill-driven recommendations for job transition pathways.
    PLoS One. 2021;16:e0254722.
    PubMed         Abstract available
    
    
97. WORONIK A, Shaffer HW, Kiontke K, Laurent JM, et al
    EUAdb: A resource for COVID-19 test development and comparison.
    PLoS One. 2021;16:e0255417.
    PubMed         Abstract available
    
    
98. DUPUIS C, de Montmollin E, Buetti N, Goldgran-Toledano D, et al
    Impact of early corticosteroids on 60-day mortality in critically ill patients with COVID-19: A multicenter cohort study of the OUTCOMEREA network.
    PLoS One. 2021;16:e0255644.
    PubMed         Abstract available
    
    
99. CHEN Y, Volic I
    Topological data analysis model for the spread of the coronavirus.
    PLoS One. 2021;16:e0255584.
    PubMed         Abstract available
    
    
100. UPHOFF EP, Lombardo C, Johnston G, Weeks L, et al
     Mental health among healthcare workers and other vulnerable groups during the COVID-19 pandemic and other coronavirus outbreaks: A rapid systematic review.
     PLoS One. 2021;16:e0254821.
     PubMed         Abstract available
     
     
101. GONZALEZ-BLOCK MA, Pelcastre-Villafuerte BE, Riva Knauth D, Fachel-Leal A, et al
     Influenza vaccination hesitancy in large urban centers in South America. Qualitative analysis of confidence, complacency and convenience across risk groups.
     PLoS One. 2021;16:e0256040.
     PubMed         Abstract available
     
     
102. ALABDULWAHHAB KM, Kazmi SY, Sami W, Almujel KN, et al
     Use of online resources by undergraduate medical students at College of Medicine, Majmaah University, Kingdom of Saudi Arabia.
     PLoS One. 2021;16:e0255635.
     PubMed         Abstract available
     
     
103. POMMERENKE C, Rand U, Uphoff CC, Nagel S, et al
     Identification of cell lines CL-14, CL-40 and CAL-51 as suitable models for SARS-CoV-2 infection studies.
     PLoS One. 2021;16:e0255622.
     PubMed         Abstract available
     
     

     
     Proc Natl Acad Sci U S A

104. SINCLAIR AH, Hakimi S, Stanley ML, Adcock RA, et al
     Pairing facts with imagined consequences improves pandemic-related risk perception.
     Proc Natl Acad Sci U S A. 2021;118.
     PubMed         Abstract available
     
     
105. KIM E, Attia Z, Woodfint RM, Zeng C, et al
     Inhibition of elastase enhances the adjuvanticity of alum and promotes anti-SARS-CoV-2 systemic and mucosal immunity.
     Proc Natl Acad Sci U S A. 2021;118.
     PubMed         Abstract available
     
     

     
     Vaccine

106. HAYMAN B, Suri R, Prasad SD
     COVID-19 vaccine capacity: Challenges and mitigation - The DCVMN perspective.
     Vaccine. 2021 Jul 13. pii: S0264-410X(21)00866.
     PubMed         Abstract available
     
     
107. PETRIE JG, Fligiel H, Lamerato L, Martin ET, et al
     Agreement between state registry, health record, and self-report of influenza vaccination.
     Vaccine. 2021 Aug 9. pii: S0264-410X(21)00995.
     PubMed         Abstract available
     
     
108. LYTLE KL, Collins SP, Feldstein LR, Baughman AH, et al
     Influenza vaccine acceptance and hesitancy among adults hospitalized with severe acute respiratory illnesses, United States 2019-2020.
     Vaccine. 2021 Aug 7. pii: S0264-410X(21)00948.
     PubMed         Abstract available
     
     
109. SAKALA IG, Honda-Okubo Y, Li L, Baldwin J, et al
     A M2 protein-based universal influenza vaccine containing Advax-SM adjuvant provides newborn protection via maternal or neonatal immunization.
     Vaccine. 2021 Aug 3. pii: S0264-410X(21)00914.
     PubMed         Abstract available
     
     
110. MATHIVATHANAN K
     Will COVID-19 vaccine equity be possible in India?
     Vaccine. 2021 Jul 22. pii: S0264-410X(21)00927.
     PubMed        
     
     
111. HAUPT RE, Harberts EM, Kitz RJ, Strohmeier S, et al
     Novel TLR4 adjuvant elicits protection against homologous and heterologous Influenza A infection.
     Vaccine. 2021 Aug 3. pii: S0264-410X(21)00847.
     PubMed         Abstract available
     
     
112. YU VG, Lasco G, David CC
     Fear, mistrust, and vaccine hesitancy: Narratives of the dengue vaccine controversy in the Philippines.
     Vaccine. 2021 Jul 27. pii: S0264-410X(21)00929.
     PubMed         Abstract available
     
     
113. BANKS C, Portnoy A, Moi F, Boonstoppel L, et al
     Cost of vaccine delivery strategies in low- and middle-income countries during the COVID-19 pandemic.
     Vaccine. 2021 Jun 29. pii: S0264-410X(21)00838.
     PubMed         Abstract available
     
     
114. LAUFER RS, Driscoll AJ, Baral R, Buchwald AG, et al
     Cost-effectiveness of infant respiratory syncytial virus preventive interventions in Mali: A modeling study to inform policy and investment decisions.
     Vaccine. 2021;39:5037-5045.
     PubMed         Abstract available
     
     
115. FUJIMOTO AB, Keskinocak P, Yildirim I
     Significance of SARS-CoV-2 specific antibody testing during COVID-19 vaccine allocation.
     Vaccine. 2021 Jun 26. pii: S0264-410X(21)00828.
     PubMed         Abstract available
     
     
116. PAUL E, Brown GW, Kalk A, Ridde V, et al
     Playing vaccine roulette: Why the current strategy of staking everything on Covid-19 vaccines is a high-stakes wager.
     Vaccine. 2021 Jul 20. pii: S0264-410X(21)00923.
     PubMed        
     
     
117. LAZAROS G, Klein AL, Hatziantoniou S, Tsioufis C, et al
     The Novel Platform of mRNA COVID-19 Vaccines and Myocarditis: Clues into the Potential Underlying Mechanism.
     Vaccine. 2021 Jul 13. pii: S0264-410X(21)00875.
     PubMed        
     
     
118. FLUCKIGER AC, Ontsouka B, Bozic J, Diress A, et al
     An enveloped virus-like particle vaccine expressing a stabilized prefusion form of the SARS-CoV-2 spike protein elicits highly potent immunity.
     Vaccine. 2021 Jul 16. pii: S0264-410X(21)00911.
     PubMed         Abstract available
     
     
119. INSERRA F, Tajer C, Antonietti L, Mariani J, et al
     Vitamin D supplementation: An alternative to enhance the effectiveness of vaccines against SARS-CoV-2?
     Vaccine. 2021 Jul 16. pii: S0264-410X(21)00908.
     PubMed        
     
     

     
     Virology

120. MENNE Z, Pliasas VC, Compans RW, Glover S, et al
     Bivalent vaccination with NA1 and NA2 neuraminidase virus-like particles is protective against challenge with H1N1 and H3N2 influenza A viruses in a murine model.
     Virology. 2021;562:197-208.
     PubMed         Abstract available
     
     

     
     Virus Res

121. EMAM M, Oweda M, Antunes A, El-Hadidi M, et al
     Positive selection as a key player for SARS-CoV-2 pathogenicity: Insights into ORF1ab, S and E genes.
     Virus Res. 2021;302:198472.
     PubMed         Abstract available
     
     
122. HAQUE MFU, Bukhari SS, Ejaz R, Zaman FU, et al
     A novel RdRp-based colorimetric RT-LAMP assay for rapid and sensitive detection of SARS-CoV-2 in clinical and sewage samples from Pakistan.
     Virus Res. 2021;302:198484.
     PubMed         Abstract available
     
     
123. DOERFLER W
     Viral Vector DNA- and RNA-Based SARS-CoV-2 Vaccines: Possible Integration into the Human Genome Are Adenoviral Genes Expressed in Vector-based Vaccines?
     Virus Res. 2021 Jun 1:198466. doi: 10.1016/j.virusres.2021.198466.
     PubMed         Abstract available
     
     
124. STEGMANN KM, Dickmanns A, Gerber S, Nikolova V, et al
     The folate antagonist methotrexate diminishes replication of the coronavirus SARS-CoV-2 and enhances the antiviral efficacy of remdesivir in cell culture models.
     Virus Res. 2021;302:198469.
     PubMed         Abstract available
     
     
125. GORAICHUK IV, Arefiev V, Stegniy BT, Gerilovych AP, et al
     Zoonotic and Reverse Zoonotic Transmissibility of SARS-CoV-2.
     Virus Res. 2021;302:198473.
     PubMed         Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: